Genetic mouse models of the NO receptor 'soluble' guanylyl cyclases

Handbook of Experimental Pharmacology

Volumn 191, Issue , 2009, Pages 33-46

  Mergia, Evanthia ^a   Koesling, Doris ^a   Friebe, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; NITRIC OXIDE; CELL RECEPTOR; CYCLIC GMP; ISOPROTEIN; SOLUBLE GUANYLYL CYCLASE; UNCLASSIFIED DRUG;

BLOOD PRESSURE; CORPUS CAVERNOSUM; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GASTROINTESTINAL TRACT; GENETICS; KNOCKOUT MOUSE; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; SYNAPTIC TRANSMISSION; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASODILATATION; ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; METABOLISM; MOUSE; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP; GUANYLATE CYCLASE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MODELS, GENETIC; NITRIC OXIDE; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 61749095566     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-68964-5_3     Document Type: Review

References (55)

1. Andersson KE, Wagner G (1995) Physiology of penile erection. Physiol Rev 75:191-236
2. Antl M, von Brühl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, Wilm M, Hofmann F, Massberg S, Schlossmann J (2007) IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 109:552-559
3. Behrends S, Vehse K (2000) The beta(2) subunit of soluble guanylyl cyclase contains a humanspecific frameshift and is expressed in gastric carcinoma. Biochem Biophys Res Commun 271:64-69
4. Bon CL, Garthwaite J (2003) On the role of nitric oxide in hippocampal long-term potentiation. J Neurosci 23:1941-1948
5. Buys ES, Sips P, Vermeersch P, Raher MJ, Rogge E, Ichinose F, Dewerchin M, Bloch KD, Janssens S, Brouckaert P (2008) Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice. Cardiovascular Research Advance Access published on March 13, doi:10.1093/cvr/cvn068
6. Chataigneau T, Félétou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM (1999) Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126:219-226
7. Chrisman TD, Garbers DL, Parks MA, Hardman JG (1975) Characterization of particulate and soluble guanylate cyclases from rat lung. J Biol Chem 250:374-381
8. Crane MS, Rossi AG,Megson IL (2005) A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations. Br J Pharmacol 144:849-859
9. Eliasson MJ, Blackshaw S, Schell MJ, Snyder SH (1997) Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci USA 94:3396-3401
10. Friebe A, Mergia E, Dangel O, Lange A, Koesling D (2007) Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci USA 104:7699-7704
11. Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706
12. Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388
13. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a] quinoxalin-1-one. Mol Pharmacol 48:184-188
14. Gerzer R, Hofmann F, Schultz G (1981a) Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem 116:479-486
15. Gerzer R, Böhme E, Hofmann F, Schultz G (1981b) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132:71-74
16. Gyurko R, Leupen S, Huang PL (2002) Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. Endocrinology 143:2767-2774
17. Haghikia A,Mergia E, Friebe A, Eysel UT, Koesling D,Mittmann T (2007) Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases. Neuroscience 27: 818-823
18. Hawkins RD, Son H, Arancio O (1998) Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res 118:155-172
19. Hopper RA, Garthwaite J (2006) Tonic and phasic nitric oxide signals in signals in hippocampal long-term potentiation. J Neurosci 26:11513-11521
20. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286
21. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242
22. Hurt KJ, Sezen SF, Champion HC, Crone JK, Palese MA, Huang PL, Sawa A, Luo X, Musicki B, Snyder SH, Burnett AL (2006) Alternatively spliced neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci USA 103:3440-3443
23. Ichinose F, Roberts JD Jr, Zapol WM (2004) Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation 109:3106-3111
24. Kamisaki Y, Saheki S, Nakane M, Palmieri JA, Kuno T, Chang BY,Waldman SA, Murad F (1986) Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem 261:7236-7241
25. Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C (2001) Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 104:2338-2343
26. Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C (2005) Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. J Mol Cell Cardiol 38:175-184
27. Koesling D, Böhme E, Schultz G (1991) Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J 13:2785-2791
28. Kuno T, Andresen JW, Kamisaki Y, Waldman SA, Chang LY, Saheki S, Leitman DC, Nakane M, Murad F (1986) Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 261:5817-5823
29. Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, Fässler R, Ruth P, Krombach F, Hofmann F (1999) Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. J Exp Med 189:1255-1264
30. Mergia E, Russwurm M, Zoidl G, Koesling D (2003) Major occurrence of the new a2b1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signal 15:189-195
31. Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D (2006) Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116:1731-1737
32. Moncada S, RadomskiMW, Palmer RM (1998) Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495-2501
33. Morishita T, TsutsuiM, Shimokawa H, Sabanai K, Tasaki H, Suda O, Nakata S, Tanimoto A,Wang KY, Ueta Y, Sasaguri Y, Nakashima Y, Yanagihara N (2005) Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci USA. 102:10616-21
34. Musicki B, Burnett AL (2006) eNOS function and dysfunction in the penis. Exp Biol Med (Maywood) 231:154-165
35. Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J (2007a) Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation. Cardiovasc Res 76:149-159
36. Nimmegeers S, Sips P, Buys E, Decaluwé K, Brouckaert P, Van de Voorde J (2007b) Role of the soluble guanylyl cyclase alpha(1)-subunit in mice corpus cavernosum smooth muscle relaxation. Int J Impot Res in press
37. Ny L, Pfeifer A, Aszòdi A, AhmadM, Alm P, Hedlund P, Fässler R, Andersson KE (2000) Impaired relaxation of stomach smooth muscle in mice lacking cyclic GMP-dependent protein kinase I. Br J Pharmacol 129:395-401
38. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O (1991) Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88:11285-11289
39. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
40. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszódi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fässler R, Hofmann F (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17:3045-3051
41. Rees DD, Palmer RM, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375-3378
42. Russwurm M, Behrends S, Harteneck C, Koesling D (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J 335:125-130
43. Russwurm M, Wittau N, Koesling D (2001) Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem 276:44647-44652
44. Saur D, Neuhuber WL, Gengenbach B, Huber A, Schusdziarra V, Allescher HD (2002) Sitespecific gene expression of nNOS variants in distinct functional regions of rat gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 282:G349-G358
45. Schultz G, Böhme E, Munske K (1969) Guanyl cyclase. Determination of enzyme activity. Life Sci 8:1323-1332
46. Schuman EM, Madison DV (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:1503-1506
47. Son H, Hawkins RD,Martin K, KieblerM, Huang PL, Fishman MC, Kandel ER (1996) Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 13:1015-1023
48. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH, Zapol WM (1998) Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101: 2468-2477
49. Thoonen R, Buys E, Sips P, van den Hemel M, Hochepied M, Derore A, Brouckaert P (2007) Targeting the NO-cGMP pathway: Phenotyping of NO-insensitive sGCbeta1H105 knockin mice. 3rd International Conference on cGMP, Poster-Abstract.
50. Van Vliet BN, Chafe LL, Montani JP (2003) Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57Bl/6J control mice. J. Physiol 549:313-325
51. Vanneste G, Dhaese I, Sips P, Buys E, Brouckaert P, Lefebvre RA (2007) Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice. J Physiol 584:907-920
52. Vermeersch P, Buys E, Pokreisz P, Marsboom G, Ichinose F, Sips P, Pellens M, Gillijns H, Swinnen M, Graveline A, Collen D, Dewerchin M, Brouckaert P, Bloch KD, Janssens S (2007) Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Circulation 116:936-943
53. Wanstall JC, Homer KL, Doggrell SA (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol 3:41-53
54. Wilson RI, Yanovsky J, Godecke A, Stevens DR, Schrader J, Haas HL (1997) Endothelial nitric oxide synthase and LTP. Nature 386:338
55. Wilson RI, Godecke A, Brown RE, Schrader J, Haas HL (1999) Mice deficient in endothelial nitric oxide synthase exhibit a selective deficit in hippocampal long-term potentiation. Neuroscience 90:1157-1165